Prediction of Severity of Drug-Drug Interactions Caused by Enzyme Inhibition and Activation
Open Access
- 31 October 2019
- Vol. 24 (21), 3955
- https://doi.org/10.3390/molecules24213955
Abstract
Drug-drug interactions (DDIs) severity assessment is a crucial problem because polypharmacy is increasingly common in modern medical practice. Many DDIs are caused by alterations of the plasma concentrations of one drug due to another drug inhibiting and/or inducing the metabolism or transporter-mediated disposition of the victim drug. Accurate assessment of clinically relevant DDIs for novel drug candidates represents one of the significant tasks of contemporary drug research and development and is important for practicing physicians. This work is a development of our previous investigations and aimed to create a model for the severity of DDIs prediction. PASS program and PoSMNA descriptors were implemented for prediction of all five classes of DDIs severity according to OpeRational ClassificAtion (ORCA) system: contraindicated (class 1), provisionally contraindicated (class 2), conditional (class 3), minimal risk (class 4), no interaction (class 5). Prediction can be carried out both for known drugs and for new, not yet synthesized substances using only their structural formulas. Created model provides an assessment of DDIs severity by prediction of different ORCA classes from the first most dangerous class to the fifth class when DDIs do not take place in the human organism. The average accuracy of DDIs class prediction is about 0.75.This publication has 21 references indexed in Scilit:
- QSAR Modeling and Prediction of Drug–Drug InteractionsMolecular Pharmaceutics, 2016
- Label Propagation Prediction of Drug-Drug Interactions Based on Clinical Side EffectsScientific Reports, 2015
- In Silico Predictions of Drug – Drug Interactions Caused by CYP1A2, 2C9 and 3A4 Inhibition – a Comparative Study of Virtual Screening PerformanceMolecular Informatics, 2015
- SOMP: web server for in silico prediction of sites of metabolism for drug-like compoundsBioinformatics, 2015
- Similarity-based modeling in large-scale prediction of drug-drug interactionsNature Protocols, 2014
- Machine learning-based prediction of drug–drug interactions by integrating drug phenotypic, therapeutic, chemical, and genomic propertiesJournal of the American Medical Informatics Association, 2014
- Literature Based Drug Interaction Prediction with Clinical Assessment Using Electronic Medical Records: Novel Myopathy Associated Drug InteractionsPLoS Computational Biology, 2012
- Polypharmacy in the elderly: A literature reviewJournal of the American Academy of Nurse Practitioners, 2005
- ORCA: OpeRational ClassificAtion of Drug InteractionsJournal of the American Pharmaceutical Association, 2001
- Emerging role of drug interaction studies in drug development: the good, the bad, and the unknown.2001